MALMOREDE Drug Patent Profile
✉ Email this page to a colleague
When do Malmorede patents expire, and when can generic versions of Malmorede launch?
Malmorede is a drug marketed by Novast Labs and is included in one NDA.
The generic ingredient in MALMOREDE is ethinyl estradiol; ethynodiol diacetate. There are twenty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; ethynodiol diacetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MALMOREDE?
- What are the global sales for MALMOREDE?
- What is Average Wholesale Price for MALMOREDE?
Summary for MALMOREDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | MALMOREDE at DailyMed |
US Patents and Regulatory Information for MALMOREDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs | MALMOREDE | ethinyl estradiol; ethynodiol diacetate | TABLET;ORAL-28 | 209547-001 | Jul 25, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
